Filgrastim Biosimilars Market Size is predicted to expand with a 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Governments around the world are promoting the use of biosimilars through various initiatives aimed at enhancing affordability and access. Filgrastim biosimilars have been shown to be effective and safe for managing neutropenia in cancer patients, which enhances their ado...
Report ID: 1076 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 175
Trastuzumab Biosimilar Market is expected to grow at a 25.0 % CAGR during the forecast period for 2025-2034. Trastuzumab is a recombinant DNA-derived humanized monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2). HER2 is over expressed in some types breast cancer cells hence, trastuzumab is mainly indicated for the treatment of HER2 positive breast cancer as well as it is also approved for the treatment of metasta...
Report ID: 1080 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Oncolytic Virus Therapy Market is estimated to grow at a 24.5% CAGR during the forecast period for 2025-2034. In recent decades, the healthcare burden of Cancer increasing rapidly with an increasing incidence rate. The massive investment in research and development has been implemented to find innovative drugs/therapy/Immuno oncology solutions to cure cancer. Some of them gaining interest include oncolytic viruses therapy, stem cell therapies,...
Report ID: 1087 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
The Psoriasis Biosimilars Market Size is valued at USD 8.5 billion in 2023 and is predicted to reach USD 19.3 billion by the year 2031 at a 10.9% CAGR during the forecast period for 2024-2031. Biosimilars for psoriasis are economically viable substitutes for original biologics employed in the management of moderate to severe psoriasis. These medications closely mimic the original biologics, such as Humira, Enbrel, and Remicade, targeting immun...
Report ID: 2891 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 160
Therapeutic Plasma Exchange Market is expected to grow at an 5.5% CAGR during the forecast period for 2025-2034. Plasma exchange is a biological procedure that removes large-molecular-weight substances such as harmful antibodies from the plasma. In this procedure, a large portion of plasma containing abnormal matter and toxins are removed from the components of WBCs, RBCs, and platelets and then replaced with replacement fluid, like fresh froz...
Report ID: 1120 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Veterinary Antibiotics Market Size is valued at USD 4.99 Billion in 2024 and is predicted to reach USD 6.95 Billion by the year 2034 at a 3.5 % CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The market is in great demand due to the increasing number of pet diseases worldwide, which leads to market growth. The need for efficient veterinary antibiotic treatments is driven by the rising in...
Report ID: 1128 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Next-Generation mRNA Capping Technologies Market Size is predicted to reach grow at an 9.7% CAGR during the forecast period for 2025-2034. Next-generation mRNA capping technologies are advanced techniques developed to optimize the addition of the 5′ cap structure to synthetic mRNA molecules. This cap is essential for mRNA stability, efficient translation into proteins, and evasion of immune detection. Unlike conventional methods, t...
Report ID: 2954 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Global Biosimilar Monoclonal Antibodies Market Size is valued at USD 7.8 Billion in 2024 and is predicted to reach USD 32.1 Billion by the year 2034 at a 15.3% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The rising occurence of chronic diseases like cancer, autoimmune disorders, and inflammatory diseases is driving the biosimilar monoclonal antibodies market. The te...
Report ID: 1218 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Global Non-Invasive Aesthetic Treatment Market size is valued at USD 25.7 Bn in 2024 and is predicted to reach USD 63.8 Bn by the year 2034 at a 9.9% CAGR during the forecast period for 2025-2034. Non-invasive aesthetic treatments encompass a wide range of cosmetic procedures and therapies intended to improve a person's look without requiring intrusive techniques or surgical incisions. Many technologies, including lasers, ultrasound, radiofreque...
Report ID: 3092 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Global Real World Evidence (RWE) Oncology Market size is valued at USD 772.5 Mn in 2024 and is predicted to reach USD 2,373.9 Mn by the year 2034 at a 12.1% CAGR during the forecast period for 2025-2034. Real-world evidence (RWE) is the term used in the healthcare industry to describe data and information obtained from patient experiences, real-world clinical practice, and other non-clinical study situations. For oncologists to understand how ca...
Report ID: 3093 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 170
Pharmaceuticals